Trial Profile
Evaluation of Olmesartan on the Control of Morning Blood Pressure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2014
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 02 Mar 2011 New trial record